Shanghai Henlius Biotech, Inc.
HKEX:2696.HK
21.45 (HKD) • At close November 5, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) HKD.
| 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2022 Q1 | 2021 Q4 | 2021 Q3 | 2021 Q2 | 2021 Q1 | 2020 Q4 | 2020 Q3 | 2020 Q2 | 2020 Q1 | 2019 Q4 | 2019 Q3 | 2019 Q2 | 2019 Q1 | 2018 Q4 | 2018 Q3 | 2018 Q2 | 2018 Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 1,373.055 | 1,373.055 | 1,467.099 | 1,427.34 | 1,250.235 | 1,250.235 | 1,080.511 | 844.825 | 644.697 | 644.697 | 524.439 | 524.439 | 316.798 | 316.798 | 238.597 | 238.597 | 55.196 | 55.196 | 36.945 | 36.945 | 16.115 | 0.924 | 3.711 | 3.711 | 0 | 0 |
| Cost of Revenue
| 377.707 | 377.707 | 347.593 | 406.881 | 360.819 | 360.819 | 329.944 | 209.068 | 152.805 | 152.805 | 150.666 | 150.666 | 110.709 | 110.709 | 61.876 | 61.876 | 29.184 | 29.184 | 30.263 | 30.263 | 11.296 | 0 | 2.699 | 2.699 | 0 | 0 |
| Gross Profit
| 995.348 | 995.348 | 1,119.506 | 1,020.459 | 889.416 | 889.416 | 750.567 | 635.757 | 491.893 | 491.893 | 373.773 | 373.773 | 206.089 | 206.089 | 176.721 | 176.721 | 26.013 | 26.013 | 6.683 | 6.683 | 4.819 | 0.924 | 1.012 | 1.012 | 0 | 0 |
| Gross Profit Ratio
| 0.725 | 0.725 | 0.763 | 0.715 | 0.711 | 0.711 | 0.695 | 0.753 | 0.763 | 0.763 | 0.713 | 0.713 | 0.651 | 0.651 | 0.741 | 0.741 | 0.471 | 0.471 | 0.181 | 0.181 | 0.299 | 1 | 0.273 | 0.273 | 0 | 0 |
| Reseach & Development Expenses
| 241.233 | 241.233 | 301.131 | 269.773 | 273.914 | 273.914 | 491.23 | 368.787 | 267.248 | 267.248 | 286.059 | 286.059 | 225.907 | 225.907 | 250.585 | 250.585 | 196.488 | 196.488 | 191.335 | 191.335 | 125.013 | 100.145 | 108.037 | 108.037 | 100.088 | 49.221 |
| General & Administrative Expenses
| 79.975 | 79.975 | 123.671 | 96.461 | 81.854 | 81.854 | 111.166 | 82.335 | 80.269 | 80.269 | 81.152 | 81.152 | 59.152 | 59.152 | 62.833 | 62.833 | 31.601 | 31.601 | 54.391 | 54.391 | 48.413 | 17.64 | 35.505 | 35.505 | 33.646 | 4.395 |
| Selling & Marketing Expenses
| 450.109 | 450.109 | 522.028 | 449.259 | 391.477 | 391.477 | 388.256 | 282.394 | 189.321 | 189.321 | 161.465 | 161.465 | 98.666 | 98.666 | 93.536 | 93.536 | 28.289 | 28.289 | 16.39 | 16.39 | 7.828 | 5.082 | 0 | 0 | 0 | 0 |
| SG&A
| 530.083 | 530.083 | 645.699 | 545.72 | 473.696 | 473.696 | 499.422 | 364.729 | 270.13 | 270.13 | 242.593 | 242.593 | 157.928 | 157.928 | 158.033 | 158.033 | 60.105 | 60.105 | 70.78 | 70.78 | 56.241 | 22.722 | 35.505 | 35.505 | 33.646 | 4.395 |
| Other Expenses
| 0 | 0 | -2.545 | -4.951 | 0 | 0 | -196.54 | 92.283 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -15.614 | 13.162 | 0 | 0 | -10.882 | 10.653 |
| Operating Expenses
| 771.316 | 771.316 | 922.818 | 794.196 | 741.762 | 741.762 | 950.548 | 726.687 | 592.188 | 592.188 | 633.544 | 633.544 | 383.621 | 383.621 | 435.762 | 435.762 | 245.592 | 245.592 | 275.792 | 275.792 | 165.64 | 136.029 | 139.231 | 139.231 | 122.852 | 64.269 |
| Operating Income
| 224.032 | 224.032 | 193.831 | 217.817 | 141.807 | 141.807 | -425.833 | 38.063 | -45.486 | -45.486 | -154.878 | -154.878 | -177.746 | -177.746 | -231.896 | -231.896 | -230.58 | -230.58 | -255.432 | -255.432 | -146.365 | -149.168 | -142.53 | -142.53 | -120.986 | -45.873 |
| Operating Income Ratio
| 0.163 | 0.163 | 0.132 | 0.153 | 0.113 | 0.113 | -0.394 | 0.045 | -0.071 | -0.071 | -0.295 | -0.295 | -0.561 | -0.561 | -0.972 | -0.972 | -4.177 | -4.177 | -6.914 | -6.914 | -9.083 | -161.437 | -38.412 | -38.412 | 0 | 0 |
| Total Other Income Expenses Net
| -26.173 | -26.173 | -36.004 | -50.002 | -19.839 | -19.839 | 73.492 | -128.467 | -80.086 | -80.086 | -126.573 | -126.573 | -19.173 | -19.173 | -40.884 | -40.884 | 6.589 | 6.589 | -23.508 | -23.508 | -12.442 | -8.955 | -7.859 | -7.859 | -13.329 | -19.256 |
| Income Before Tax
| 197.859 | 197.859 | 157.827 | 167.815 | 121.968 | 121.968 | -352.341 | -90.404 | -125.571 | -125.571 | -281.451 | -281.451 | -196.919 | -196.919 | -272.78 | -272.78 | -223.991 | -223.991 | -278.94 | -278.94 | -158.807 | -158.123 | -150.388 | -150.388 | -134.315 | -65.129 |
| Income Before Tax Ratio
| 0.144 | 0.144 | 0.108 | 0.118 | 0.098 | 0.098 | -0.326 | -0.107 | -0.195 | -0.195 | -0.537 | -0.537 | -0.622 | -0.622 | -1.143 | -1.143 | -4.058 | -4.058 | -7.55 | -7.55 | -9.855 | -171.129 | -40.53 | -40.53 | 0 | 0 |
| Income Tax Expense
| 4.709 | 4.709 | 19.603 | 81.118 | 1.978 | 1.978 | 0.419 | 0.21 | 0.477 | 0.477 | 13.657 | 13.657 | 0 | 0 | 0 | 0 | 0 | 0 | 0.328 | 0.328 | 12.442 | 8.955 | 0.623 | 0.623 | 0.609 | 2.714 |
| Net Income
| 193.151 | 193.151 | 138.224 | 167.815 | 119.99 | 119.99 | -352.76 | -90.404 | -126.048 | -126.048 | -295.108 | -295.108 | -196.919 | -196.919 | -272.78 | -272.78 | -223.991 | -223.991 | -279.268 | -279.268 | -171.249 | -167.078 | -151.011 | -151.011 | -134.924 | -67.843 |
| Net Income Ratio
| 0.141 | 0.141 | 0.094 | 0.118 | 0.096 | 0.096 | -0.326 | -0.107 | -0.196 | -0.196 | -0.563 | -0.563 | -0.622 | -0.622 | -1.143 | -1.143 | -4.058 | -4.058 | -7.559 | -7.559 | -10.627 | -180.82 | -40.698 | -40.698 | 0 | 0 |
| EPS
| 0.36 | 0.36 | 0.25 | 0.31 | 0.22 | 0.22 | -0.65 | -0.17 | -0.24 | -0.24 | -0.55 | -0.55 | -0.37 | -0.37 | -0.51 | -0.51 | -0.43 | -0.43 | -0.51 | -0.51 | -0.33 | -0.32 | -0.32 | -0.299 | -0.25 | -0.13 |
| EPS Diluted
| 0.36 | 0.36 | 0.25 | 0.31 | 0.22 | 0.22 | -0.65 | -0.17 | -0.23 | -0.23 | -0.55 | -0.55 | -0.37 | -0.37 | -0.51 | -0.51 | -0.43 | -0.43 | -0.51 | -0.51 | -0.32 | -0.31 | -0.32 | -0.298 | -0.25 | -0.13 |
| EBITDA
| 293.174 | 293.174 | 309.507 | 298.895 | 205.628 | 205.628 | -338.847 | 137.563 | -9.933 | -9.933 | -117.576 | -117.576 | -141.572 | -141.572 | -204.019 | -204.019 | -211.715 | -211.715 | -238.621 | -238.621 | -127.648 | -136.586 | -136.602 | -136.602 | -110.788 | -36.352 |
| EBITDA Ratio
| 0.214 | 0.214 | 0.211 | 0.209 | 0.164 | 0.164 | -0.314 | 0.163 | -0.015 | -0.015 | -0.224 | -0.224 | -0.447 | -0.447 | -0.855 | -0.855 | -3.836 | -3.836 | -6.459 | -6.459 | -7.921 | -147.82 | -36.815 | -36.815 | 0 | 0 |